Efficacy and safety analysis of bortezomib-based triplet regimens sequential lenalidomide in newly diagnosed multiple myeloma patients

The aim of this study is to analyze the efficacy and safety of sequential therapy with bortezomib-based triplet regimens without lenalidomide (PXD, including VTD, PAD, and VCD) followed by continuous lenalidomide and dexamethasone (Rd) or bortezomib and dexamethasone (Vd) treatment. The main objecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Qiaolin, Xu, Fang, Wen, Jingjing, Yue, Jing, Zhang, Ya, Su, Jing, Liu, Yiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460706/
https://www.ncbi.nlm.nih.gov/pubmed/36094683
http://dx.doi.org/10.1007/s10238-022-00879-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460706/
https://www.ncbi.nlm.nih.gov/pubmed/36094683
http://dx.doi.org/10.1007/s10238-022-00879-0

Ejemplares similares